Koyfin Home > Directory > Health Care > Abbott Laboratories > Long-Term Debt / Capital

Abbott Laboratories Long-Term Debt / Capital Chart (ABT)

Abbott Laboratories annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Abbott Laboratories Long-Term Debt / Capital for the quarter ending September 09, 2020 was $37m a 5.54% increase of 2m year over year
  • Abbott Laboratories Long-Term Debt / Capital for the last 12 months ending September 09, 2020 was $37m a 5.54% increase of 2m year over year
  • Abbott Laboratories Annual Long-Term Debt / Capital for 2019 was $35m a -11.40% decrease of -4m from 2018
  • Abbott Laboratories Annual Long-Term Debt / Capital for 2018 was $38m a -19.76% decrease of -8m from 2017
  • Abbott Laboratories Annual Long-Term Debt / Capital for 2017 was $46m a -5.00% decrease of -2m from 2016
Other Ratios Metrics:
  • Abbott Laboratories Total Debt / Capital for the quarter ending December 12, 2018 was $44m a 5.51% increase of 2m year over year
  • Abbott Laboratories Other Liabilities for the quarter ending September 09, 2018 was $8,407m a -7.41% decrease of -623m year over year
  • Abbott Laboratories Total Debt / Equity for the quarter ending December 12, 2018 was $77m a 9.36% increase of 7m year over year
View Chart On Koyfin

Quarterly ABT Long-Term Debt / Capital Data

09/2020$37m
06/2020$36m
03/2020$35m
12/2019$35m
09/2019$35m
06/2019$38m
03/2019$38m
12/2018$38m
09/2018$36m
06/2018$39m

Annual ABT Long-Term Debt / Capital Data

2019$35m
2018$38m
2017$46m
2016$48m
2015$19m
2014$12m
2013$11m
2012$38m
2011$30m
2010$30m